Business Description
Molina Healthcare Inc
NAICS : 524114
SIC : 6324
ISIN : US60855R1005
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.75 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 0.53 | |||||
Debt-to-EBITDA | 1.39 | |||||
Interest Coverage | 14.3 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.43 | |||||
Beneish M-Score | -2.09 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 21.8 | |||||
3-Year EBITDA Growth Rate | 16 | |||||
3-Year EPS without NRI Growth Rate | 23 | |||||
3-Year FCF Growth Rate | -3.7 | |||||
3-Year Book Growth Rate | 26.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 14.59 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.9 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 19.13 | |||||
9-Day RSI | 23.33 | |||||
14-Day RSI | 27.17 | |||||
6-1 Month Momentum % | 26.27 | |||||
12-1 Month Momentum % | 51.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.49 | |||||
Quick Ratio | 1.49 | |||||
Cash Ratio | 1.05 | |||||
Days Sales Outstanding | 28.17 | |||||
Days Payable | 11.85 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | 0.04 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 12.41 | |||||
Operating Margin % | 4.31 | |||||
Net Margin % | 2.99 | |||||
FCF Margin % | 2.46 | |||||
ROE % | 27.47 | |||||
ROA % | 7.41 | |||||
ROIC % | 39.62 | |||||
ROC (Joel Greenblatt) % | 545.97 | |||||
ROCE % | 24.14 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.57 | |||||
Forward PE Ratio | 14.5 | |||||
PE Ratio without NRI | 16.9 | |||||
Shiller PE Ratio | 40.42 | |||||
Price-to-Owner-Earnings | 26.04 | |||||
PEG Ratio | 1.78 | |||||
PS Ratio | 0.55 | |||||
PB Ratio | 4.46 | |||||
Price-to-Tangible-Book | 7.81 | |||||
Price-to-Free-Cash-Flow | 22.54 | |||||
Price-to-Operating-Cash-Flow | 20.69 | |||||
EV-to-EBIT | 8.74 | |||||
EV-to-Forward-EBIT | 7.13 | |||||
EV-to-EBITDA | 7.86 | |||||
EV-to-Forward-EBITDA | 6.68 | |||||
EV-to-Revenue | 0.38 | |||||
EV-to-Forward-Revenue | 0.36 | |||||
EV-to-FCF | 15.32 | |||||
Price-to-Projected-FCF | 1.07 | |||||
Price-to-Median-PS-Value | 1.2 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.79 | |||||
Price-to-Graham-Number | 2.42 | |||||
Price-to-Net-Current-Asset-Value | 12.17 | |||||
Earnings Yield (Greenblatt) % | 11.44 | |||||
FCF Yield % | 4.39 | |||||
Forward Rate of Return (Yacktman) % | 15.85 |